Black Diamond Therapeutics, Inc. (BDTX)
Black Diamond Therapeutics, Inc. is a biotechnology enterprise dedicated to discovering, advancing, and bringing to market therapeutic agents specifically designed for patients with genetically characterized tumors. A core part of its pipeline is BDTX-189, an irreversible small molecule inhibitor. This compound is engineered to neutralize oncogenic proteins driven by non-canonical epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) driver mutations. The firm is also progressing BDTX-1535, a brain-penetrant inhibitor addressing a range of EGFR mutations, including conventional, inherent resistance, and acquired resistance forms. Concurrently, it is advancing BDTX-4933, another brain-penetrant inhibitor targeting oncogenic BRAF alterations across Class I, II, and III categories. Black Diamond maintains a strategic alliance with OpenEye Scientific Software, Inc. Established in 2014, the company was initially known as ASET Therapeutics, Inc. before adopting its current name, Black Diamond Therapeutics, Inc., in January 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.
Sector: Biological Products, (No Diagnostic Substances)
Industry: Biotechnology
Black Diamond Therapeutics, Inc.
NASDAQ:BDTXHealthcare · Biotechnology
-9.62%$1.88
AH Close$1.88+0.00%vs close
AH Close$1.88+0.00%vs close
Mkt Cap$108.01M
Float42.54M
O/S57.45M
Inst Own61.0%
SI11.2%
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$70M
Net Income$22.37M
Total Assets$143.01M
Free Cash Flow$29.61M
Debt & Equity
Debt 14%
Equity 86%
Total Debt$18.78M
Total Equity$112.21M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in BDTX's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$143.01M
Liabilities$30.8M
Accounts Receivable$0
Accounts Payable$579K
Inventory$0
PP&E (Net)$9.67M
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Revenue | $70M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $325K | $0 | $437K | $0 | $0 | $0 | $47K | $44K | $24K |
| Gross Profit | $69.67M | $0 | -$437K | $0 | $0 | $0 | -$47K | -$44K | -$24K |
| Gross Margin | 99.5% | - | - | - | - | - | - | - | - |
| Research and Development | $33.56M | $51.31M | $58.91M | $64.44M | $96.83M | $48.21M | $21.75M | $6.95M | $3.45M |
| Selling, General, and Administrative | $16.57M | $27.47M | $27.11M | $28.39M | $30.04M | $21.36M | $7.58M | $1.95M | $666K |
| Other | -$325K | $0 | $0 | $0 | $0 | $0 | $0 | -$16K | -$6K |
| Total Operating Expenses | $49.8M | $78.78M | $86.02M | $92.83M | $126.87M | $69.57M | $29.33M | $8.9M | $4.12M |
| Operating Income (EBIT) | $19.87M | -$78.78M | -$86.46M | -$92.83M | -$126.87M | -$69.57M | -$8.9M | -$8.9M | -$4.12M |
| Operating Margin | 28.4% | - | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $1K | $0 | $0 | $65K |
| Interest Income | $4.06M | $2.18M | $1.92M | $2.03M | $3.46M | $4.04M | $461K | $4K | $0 |
| Other Income (Expense) | $2.5M | $9.11M | $4.02M | $1.66M | $1.28M | $2.32M | -$5.93M | -$27K | -$483K |
| Income Before Tax (EBT) | $22.37M | -$69.68M | -$82.44M | -$91.17M | -$125.6M | -$67.25M | -$35.26M | -$8.93M | -$4.6M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$27K | $0 |
| Net Income | $22.37M | -$69.68M | -$82.44M | -$91.17M | -$125.6M | -$67.25M | -$35.26M | -$8.93M | -$4.6M |
| Net Income Margin | 32.0% | - | - | - | - | - | - | - | - |
| Supplementary Data | |||||||||
| EPS | 0.39 | -1.27 | -1.88 | -2.52 | -3.47 | -2.04 | -1.15 | -0.64 | -0.64 |
| Diluted EPS | 0.39 | -1.27 | -1.88 | -2.52 | -3.47 | -2.04 | -1.15 | -0.64 | -0.64 |
| Weighted Average OS | 56.87M | 55.03M | 43.95M | 36.23M | 36.19M | 32.91M | 35.91M | 13.95M | 7.20M |
| EBITDA | $22.69M | -$69.33M | -$82M | -$90.66M | -$125.39M | -$67.2M | -$29.29M | -$8.89M | -$4.09M |
| EBITDA Margin | 32.4% | - | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Assets | |||||||||
| Current Assets | |||||||||
| Cash and Cash Equivalents | $20.99M | $36.44M | $56.22M | $34.31M | $65.8M | $34.6M | $154.67M | $51.66M | $7.88M |
| Short-Term Investments | $107.66M | $62.14M | $75.18M | $88.49M | $143.99M | $280.46M | $0 | $0 | $0 |
| Cash and Short-Term Investments | $128.65M | $98.58M | $131.4M | $122.81M | $209.79M | $315.07M | $154.67M | $51.66M | $7.88M |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $3.79M | $2.6M | $2.63M | $4.9M | $0 | $0 | $0 | $0 | $0 |
| Total Current Assets | $132.44M | $101.18M | $134.03M | $127.71M | $215.7M | $319.55M | $155.71M | $51.68M | $7.91M |
| Long-Term Assets | |||||||||
| Property, Plant & Equipment Net | $9.67M | $20.4M | $23.71M | $27.38M | $30.74M | $8.79M | $164K | $134K | $102K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $829K | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $73K | $1.07M | $823K | $1.17M | $1.24M | $1.33M | $2.42M | $8K | $5K |
| Total Long-Term Assets | $10.57M | $21.46M | $24.53M | $28.55M | $31.98M | $10.12M | $2.58M | $142K | $107K |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $143.01M | $122.64M | $158.57M | $156.25M | $247.68M | $329.67M | $158.29M | $51.83M | $8.02M |
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | $579K | $4.01M | $2.32M | $1.88M | $4.11M | $2.54M | $1.96M | $416K | $152K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Current Liabilities | $15.73M | $20.57M | $19.65M | $15.26M | $23.64M | $14.22M | $4.86M | $2.58M | $2.23M |
| Long-Term Liabilities | |||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $60.77M | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $200.59M | $4.02M | $12.47M |
| Total Long-Term Liabilities | $15.07M | $18.78M | $22.18M | $25.3M | $28.14M | $7.69M | $200.59M | $64.79M | $12.47M |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $30.8M | $39.35M | $41.83M | $40.56M | $51.78M | $21.91M | $205.45M | $67.37M | $14.7M |
| Stockholders' Equity | |||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $60.77M | $12.46M |
| Common Stock | $8K | $7K | $7K | $5K | $5K | $5K | $1K | $1K | $1K |
| Retained Earnings | -$464.74M | -$487.11M | -$417.43M | -$334.99M | -$243.82M | -$118.22M | -$50.97M | -$15.71M | -$6.78M |
| Comprehensive Income & Other | $101K | $24K | -$27K | -$1.82M | -$414K | $614K | $0 | -$100K | -$56K |
| Other Stockholders' Equity | $576.94M | $570.38M | $534.16M | $450.68M | $439.71M | $425.98M | $3.81M | $169K | $105K |
| Total Equity | $112.21M | $83.28M | $116.74M | $115.69M | $195.9M | $307.76M | -$47.16M | -$15.54M | -$6.67M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $143.01M | $122.64M | $158.57M | $156.25M | $247.68M | $329.67M | $158.29M | $51.83M | $8.02M |
| Supplementary Data | |||||||||
| Total Debt | $18.78M | $22.19M | $25.3M | $28.14M | $28.46M | $8.74M | $0 | $60.77M | $12.46M |
| Net Debt | -$2.21M | -$14.25M | -$30.92M | -$6.17M | -$37.34M | -$25.86M | -$154.67M | $9.11M | $4.58M |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
| Operating Activities | |||||||||
| Net Income | $22.37M | -$69.68M | -$82.44M | -$91.17M | -$125.6M | -$67.25M | -$35.26M | -$8.93M | -$4.6M |
| Depreciation & Amortization | $325K | $343K | $437K | $508K | $205K | $52K | $47K | $44K | $24K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $2.18M | $1.73M | $0 | $0 | $412K |
| Stock-Based Compensation | $6.63M | $10.63M | $9.6M | $12.2M | $14.04M | $7.76M | $3.64M | $64K | $5K |
| Changes in Working Capital: | |||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$3.43M | $1.68M | $597K | -$2.23M | $1.57M | $1.07M | $1.45M | $264K | -$59K |
| Other Working Capital | -$5.3M | -$4.38M | $3.09M | -$7.67M | $5.45M | $3.97M | -$991K | $90K | $1.8M |
| Total Working Capital Change | -$8.73M | -$2.69M | $3.69M | -$9.9M | $7.02M | $5.04M | $463K | $354K | $1.74M |
| Other Non-Cash Items | $9.02M | -$905K | $2M | $3.28M | $2.01M | $524K | $6.43M | $15K | $66K |
| Net Cash from Operating | $29.61M | -$62.3M | -$66.72M | -$85.08M | -$100.15M | -$52.15M | -$24.67M | -$8.45M | -$2.35M |
| Investing Activities | |||||||||
| Capital Expenditures | $0 | $0 | -$33K | -$192K | -$2.71M | -$142K | -$21K | -$76K | -$77K |
| Acquisitions | $27K | $94K | $0 | $9K | $2.7M | $118K | $0 | $0 | $0 |
| Purchases of Investments | -$164.03M | -$122.88M | -$61.89M | -$60.14M | -$49.51M | -$372.48M | $0 | $0 | $0 |
| Sales of Investments | $119.02M | $139.75M | $78.17M | $113.69M | $182.83M | $90.93M | $0 | $0 | $0 |
| Other Investing Activities | $74K | $0 | $95K | $0 | -$2.7M | -$118K | $0 | $0 | $0 |
| Net Cash from Investing | -$44.91M | $16.97M | $16.35M | $53.37M | $130.61M | -$281.69M | -$21K | -$76K | -$77K |
| Financing Activities | |||||||||
| Debt Repaid | - | - | - | - | - | - | - | - | $50K |
| Common Stock Issuance | -$146K | $24.49M | $71.85M | $177K | $729K | $213.84M | $0 | $52.31M | $100K |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $1.05M | $82K | $0 | $0 | $1.1M | -$1.74M | $0 | $10.02M |
| Net Cash from Financing | -$146K | $25.55M | $71.93M | $177K | $729K | $214.94M | $127.76M | $52.31M | $9.97M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | -$15.44M | -$19.79M | $21.56M | -$31.54M | $31.19M | -$118.89M | $103.06M | $43.78M | $7.55M |
| Supplementary Data | |||||||||
| Operating Cash Flow | $29.61M | -$62.3M | -$66.72M | -$85.08M | -$100.15M | -$52.15M | -$24.67M | -$8.45M | -$2.35M |
| Capital Expenditure | $0 | $0 | -$33K | -$192K | -$2.71M | -$142K | -$21K | -$76K | -$77K |
| Free Cash Flow | $29.61M | -$62.3M | -$66.75M | -$85.27M | -$102.86M | -$52.29M | -$24.7M | -$8.53M | -$2.43M |
| Cash at Beginning | $37.26M | $57.04M | $35.48M | $67.02M | $35.83M | $154.72M | $51.66M | $7.88M | $332K |
| Cash at End | $21.82M | $37.26M | $57.04M | $35.48M | $67.02M | $35.83M | $154.72M | $51.66M | $7.88M |